In 2023, the WHO and the O'Neill Review for Antimicrobial Resistance (AMR) have urgently called for rapid sepsis diagnostics, identifying the need for innovative diagnostics as a top 10 priority, and emphasizing the failure to develop such diagnostics.

Sepsis has been a major global cause of death for decades, affecting people of all ages. Swift pathogen identification is crucial for successful treatment and survival, and to reduce AMR emergence, but current methods like blood cultures are slow and often inconclusive, while PCR-based approaches have limited pathogen detection capabilities

 

Natantis combines the power of microfluidic engineering and real-time sequencing to provide a decentralised, under 6h solution to the identification of sepsis-causing pathogens

 

 

 

​